These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF. van Heesch MM; van Asselt AD; Evers JL; van der Hoeven MA; Dumoulin JC; van Beijsterveldt CE; Bonsel GJ; Dykgraaf RH; van Goudoever JB; Koopman-Esseboom C; Nelen WL; Steiner K; Tamminga P; Tonch N; Torrance HL; Dirksen CD Hum Reprod; 2016 Nov; 31(11):2527-2540. PubMed ID: 27907897 [TBL] [Abstract][Full Text] [Related]
6. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial. Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ; J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851 [TBL] [Abstract][Full Text] [Related]
7. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure. McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762 [TBL] [Abstract][Full Text] [Related]
8. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy. Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652 [TBL] [Abstract][Full Text] [Related]
9. Comparative cost-benefit analysis of tele-homecare for community-dwelling elderly in Japan: Non-Government versus Government Supported Funding Models. Akiyama M; Abraham C Int J Med Inform; 2017 Aug; 104():1-9. PubMed ID: 28599810 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression. Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589 [TBL] [Abstract][Full Text] [Related]
11. TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer. James N; Pirrie S; Pope A; Barton D; Andronis L; Goranitis I; Collins S; McLaren D; O'Sullivan J; Parker C; Porfiri E; Staffurth J; Stanley A; Wylie J; Beesley S; Birtle A; Brown J; Chakraborti P; Russell M; Billingham L Health Technol Assess; 2016 Jul; 20(53):1-288. PubMed ID: 27434595 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803 [TBL] [Abstract][Full Text] [Related]
13. Analyzing cost-effectiveness of ulnar and median nerve transfers to regain forearm flexion. Wali AR; Park CC; Brown JM; Mandeville R Neurosurg Focus; 2017 Mar; 42(3):E11. PubMed ID: 28245686 [TBL] [Abstract][Full Text] [Related]
14. When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature. Talmor D; Shapiro N; Greenberg D; Stone PW; Neumann PJ Crit Care Med; 2006 Nov; 34(11):2738-47. PubMed ID: 16957636 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model. Stollenwerk B; Bartmus T; Klug F; Stock S; Müller D Osteoporos Int; 2015 Apr; 26(4):1367-79. PubMed ID: 25572047 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of diagnostic imaging work-up and treatment for patients with intermittent claudication in The Netherlands. Visser K; de Vries SO; Kitslaar PJ; van Engelshoven JM; Hunink MG Eur J Vasc Endovasc Surg; 2003 Mar; 25(3):213-23. PubMed ID: 12623332 [TBL] [Abstract][Full Text] [Related]